MORGAN STANLEY - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$2,074,138
-51.6%
610,040
+4.6%
0.00%
Q2 2023$4,287,035
-17.6%
583,270
+16.1%
0.00%
-100.0%
Q1 2023$5,203,257
-32.6%
502,245
-23.2%
0.00%0.0%
Q4 2022$7,720,716
+12.3%
653,744
+99.6%
0.00%0.0%
Q3 2022$6,875,000
-68.4%
327,569
-53.2%
0.00%
-66.7%
Q2 2022$21,731,000
+20.9%
700,103
+60.0%
0.00%
+50.0%
Q1 2022$17,969,000
+67.5%
437,652
+77.3%
0.00%
+100.0%
Q4 2021$10,729,000
-27.5%
246,807
-16.5%
0.00%
-50.0%
Q3 2021$14,800,000
-49.2%
295,584
-36.1%
0.00%
-50.0%
Q2 2021$29,133,000
+42.1%
462,531
+109.7%
0.00%
+33.3%
Q1 2021$20,496,000
+45.3%
220,595
+40.2%
0.00%
+50.0%
Q4 2020$14,103,000
+369.9%
157,394
+442.0%
0.00%
+100.0%
Q3 2020$3,001,000
-73.0%
29,037
-79.4%
0.00%
-50.0%
Q2 2020$11,132,000
+53.8%
140,761
+12.6%
0.00%0.0%
Q1 2020$7,236,000
-41.3%
125,047
-45.2%
0.00%
-33.3%
Q4 2019$12,317,000
+47.7%
228,298
+43.1%
0.00%
+50.0%
Q3 2019$8,339,000
-36.3%
159,513
-41.1%
0.00%
-33.3%
Q2 2019$13,081,000
+204.3%
270,769
+218.1%
0.00%
+200.0%
Q1 2019$4,299,000
-62.1%
85,109
-55.5%
0.00%
-66.7%
Q4 2018$11,350,000
-32.2%
191,457
-24.7%
0.00%
-25.0%
Q3 2018$16,731,000
+88.9%
254,168
+44.9%
0.00%
+100.0%
Q2 2018$8,859,000
+14.9%
175,468
+19.9%
0.00%0.0%
Q1 2018$7,707,000
-37.4%
146,377
-44.7%
0.00%
-33.3%
Q4 2017$12,310,000
+96.6%
264,885
+71.1%
0.00%
+50.0%
Q3 2017$6,262,000
+69.5%
154,806
+42.1%
0.00%
+100.0%
Q2 2017$3,695,000
-42.9%
108,944
-51.2%
0.00%0.0%
Q1 2017$6,476,000
-35.9%
223,034
-27.5%
0.00%
-50.0%
Q4 2016$10,106,000
+954.9%
307,760
+911.9%
0.00%
Q3 2016$958,000
-94.7%
30,413
-95.2%
0.00%
-100.0%
Q2 2016$17,959,000
+272.4%
638,639
+381.3%
0.01%
+200.0%
Q1 2016$4,823,000
+133.3%
132,697
+156.9%
0.00%
+100.0%
Q4 2015$2,067,000
+31.3%
51,655
-6.4%
0.00%0.0%
Q3 2015$1,574,000
+216.1%
55,210
+265.9%
0.00%
Q2 2015$498,000
-50.9%
15,088
-57.3%
0.00%
Q1 2015$1,014,000
+281.2%
35,294
+259.6%
0.00%
Q4 2014$266,000
-54.0%
9,814
-63.8%
0.00%
Q3 2014$578,000
-85.5%
27,135
-84.7%
0.00%
-100.0%
Q2 2014$3,984,000
-29.4%
177,412
-20.6%
0.00%0.0%
Q1 2014$5,643,000
+84.5%
223,305
+67.9%
0.00%
+100.0%
Q4 2013$3,058,000133,0260.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Broadfin Capital, LLC 2,080,519$44,336,0004.65%
GREAT POINT PARTNERS LLC 290,000$6,180,0002.65%
FIDUCIARY MANAGEMENT ASSOCIATES LLC 651,884$13,892,0000.99%
Matarin Capital Management, LLC 85,003$1,811,414,0000.83%
KINGDON CAPITAL MANAGEMENT, L.L.C. 407,000$8,673,0000.39%
ICON ADVISERS INC/CO 258,478$5,508,0000.32%
RMB Capital Management, LLC 178,204$3,798,0000.23%
NEW AMSTERDAM PARTNERS LLC/NY 159,470$3,398,0000.23%
GLOBEFLEX CAPITAL L P 94,016$2,003,0000.23%
Convergence Investment Partners, LLC 58,672$1,250,0000.17%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders